Biotech
CytoMed Collaborates for Improved Allogeneic CAR γδ T In Vivo Persistence in China
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its propr...
August 16, 2023 | News
Advancing Medical Hub Vision: Thailand's First GMP Cell Therapy Facility & ASEAN Accessibility
Dr. Kitipong and Prem Mandalapu further discuss the pivotal partnership between Genepeutic Bio and Cytiva, highlighting how their collaboration contr...
August 11, 2023 | Influencers
Standigm and Nashville Biosciences join to revolutionize early drug discovery
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that it is collaborating with N...
August 11, 2023 | News
GenScript Biotech and T-MAXIMUM Biotech Form Strategic Alliance on cGMP sgRNA
GenScript Biotech, the world's leading life-science research tools and services provider, and T-MAXIMUM Biotech, a biotechnology company pioneering u...
August 10, 2023 | News
GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs
GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has ramped up production of complex and modi...
August 09, 2023 | News
Fapon Unveils High-Throughput Chemiluminescence Immunoassay Analyzer
According to Mr. Kevin Liu, Global Sales Director of Fapon, "The Shine i8000/9000 Chemiluminescence Immunoassay Analyzer boasts an extraordinary testi...
July 26, 2023 | News
US FDA Grants Orphan Drug Designation to SN Bioscience's 'SNB-101' for Small Cell Lung Cancer
SNB-101 showed excellent efficacy in animal small cell lung cancer models, and based on this, it has been designated as an orphan drug by the US FDA after ...
July 21, 2023 | News
Biotheus Partners with BioNTech in Global Research Collaboration & License Deal
Under the terms of the agreement, Biotheus will grant BioNTech worldwide, exclusive options to a preclinical-stage bispecific antibody and a clinical-stage...
July 20, 2023 | News
Merck and Telix Continue Collaboration for Targeted Radiation Therapy Studies.
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Com...
July 19, 2023 | News
Sartorius completes acquisition of Polyplus
Polyplus is a leading provider of innovative technologies for cell and gene therapies. Transfection reagents developed and produced by Polyplus are key com...
July 18, 2023 | News
SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech'
SK Biopharmaceuticals CEO Donghoon Lee maps out its medium to long-term strategy at a press conference SK Biopharmaceuticals mobilizes its cutti...
July 18, 2023 | News
Doer Biologics Announces License Agreement with BioNTech
Under the terms of the agreement, Doer Bio will grant BioNTech a worldwide license to utilize one of Doer Bio's innovative discoveries to research, develop...
July 12, 2023 | News
Thermo Fisher Scientific Introduces Tumor Culture Medium for Faster Cancer Treatment Development
Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...
June 29, 2023 | News
Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693
Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...
June 26, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
